AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PERINDOPRIL ARGININE+INDAPAMIDE
16 registrations across 4 African markets— 11 active
Markets with PERINDOPRIL ARGININE+INDAPAMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| COVERSYL PLUS 5MG/1.25MG TABLETS | 🇬🇭Ghana | — | active | Aug 2030 |
| COVERSYL PLUS 5MG/1.25MG TABLETS | 🇬🇭Ghana | — | active | Aug 2030 |
| SERDERAX 5MG/1.25MG TABLETS | 🇬🇭Ghana | — | active | Jul 2030 |
| SERDERAX 5MG/1.25MG TABLETS | 🇬🇭Ghana | — | active | Jul 2030 |
| SERDERAX 5MG/1,25MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LES LABORATOIRES SERVIER | active | Mar 2028 |
| Coversyl Plus 5 mg/1.25 mg Tablet | 🇳🇬Nigeria | Caesar & Jones Nigeria Ltd | active | Jun 2026 |
| BIPRETERAX ARGININE 10MG/2,5MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LES LABORATOIRES SERVIER | expired | Jun 2026 |
| BIPRETERAX ARGININE 5MG/1,25MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LES LABORATOIRES SERVIER | expired | Jun 2026 |
| PRETERAX ARGININE 2,5MG/0,625MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LES LABORATOIRES SERVIER | expired | Jun 2026 |
| PEROCRIL IP 5MG/1,25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Jan 2025 |
| PEROCRIL IP 10MG/2,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Jan 2025 |
| BI-THERAPRIL comprimé / 5 mg / 1,25 mg | 🇸🇳Senegal | THERA | active | — |
| COVAX comprimé / 2 mg / 625 mg | 🇸🇳Senegal | CSH PHARMACEUTICALS NORTH PVT LTD | active | — |
| SERDERAX comprime pellicule / 10 mg / 2,5 mg | 🇸🇳Senegal | SERVIER | active | — |
| SERDERAX comprime pellicule / 5 mg /1,25 mg | 🇸🇳Senegal | SERVIER | active | — |
| COVAX comprimé / 2 mg / 0,625 mg | 🇸🇳Senegal | CSH PHARMACEUTICALS NORTH PVT LTD | active | — |
PERINDOPRIL ARGININE+INDAPAMIDE in Africa — Regulatory Overview
PERINDOPRIL ARGININE+INDAPAMIDE is registered across 4 African markets with 16 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal, Ghana, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 16 registrations, 11 (69%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.